[{"id": 153261, "created": "2022-02-07T09:48:58.023423", "project_id": 65, "task_id": 183686, "user_id": 168, "user_ip": null, "finish_time": "2022-02-07T09:49:46.343139", "timeout": null, "calibration": null, "external_uid": null, "media_url": null, "info": {"text": "\u2022 Doktorlar Biontech-Pfizer a\u015f\u0131s\u0131n\u0131 \u00f6v\u00fcyor, kazan\u00e7lar\u0131 var? \u2714\ufe0fBu a\u015f\u0131lar \u015fu anda d\u00fcnyada etkinli\u011fi en y\u00fcksek a\u015f\u0131lar. Tek dozdan 2 hafta sonra %70-80 koruyucu. Ayr\u0131ca t\u00fcm varyantlara etkili ve bula\u015fmay\u0131 da %90\u2019\u0131n \u00fczerinde engelliyor. Biz de\u011fil, bilim \u00f6v\u00fcyor.", "file_id": "1420694273935224843", "classifier": {"q1": "yes", "q2": "IGNORED", "q3": "IGNORED", "q4": "IGNORED", "q5": "no_too_trivial_to_check", "q6": "no_not_harmful", "q7": "no_not_interesting", "comment": ""}}}, {"id": 154300, "created": "2022-02-09T07:40:15.514240", "project_id": 65, "task_id": 183686, "user_id": 175, "user_ip": null, "finish_time": "2022-02-09T07:40:46.332980", "timeout": null, "calibration": null, "external_uid": null, "media_url": null, "info": {"text": "\u2022 Doktorlar Biontech-Pfizer a\u015f\u0131s\u0131n\u0131 \u00f6v\u00fcyor, kazan\u00e7lar\u0131 var? \u2714\ufe0fBu a\u015f\u0131lar \u015fu anda d\u00fcnyada etkinli\u011fi en y\u00fcksek a\u015f\u0131lar. Tek dozdan 2 hafta sonra %70-80 koruyucu. Ayr\u0131ca t\u00fcm varyantlara etkili ve bula\u015fmay\u0131 da %90\u2019\u0131n \u00fczerinde engelliyor. Biz de\u011fil, bilim \u00f6v\u00fcyor.", "file_id": "1420694273935224843", "classifier": {"q1": "yes", "q2": "IGNORED", "q3": "IGNORED", "q4": "IGNORED", "q5": "yes_not_urgent", "q6": "no_not_harmful", "q7": "yes_discusses_cure", "comment": ""}}}, {"id": 159460, "created": "2022-02-15T10:37:30.241954", "project_id": 65, "task_id": 183686, "user_id": 180, "user_ip": null, "finish_time": "2022-02-15T10:37:44.292223", "timeout": null, "calibration": null, "external_uid": null, "media_url": null, "info": {"text": "\u2022 Doktorlar Biontech-Pfizer a\u015f\u0131s\u0131n\u0131 \u00f6v\u00fcyor, kazan\u00e7lar\u0131 var? \u2714\ufe0fBu a\u015f\u0131lar \u015fu anda d\u00fcnyada etkinli\u011fi en y\u00fcksek a\u015f\u0131lar. Tek dozdan 2 hafta sonra %70-80 koruyucu. Ayr\u0131ca t\u00fcm varyantlara etkili ve bula\u015fmay\u0131 da %90\u2019\u0131n \u00fczerinde engelliyor. Biz de\u011fil, bilim \u00f6v\u00fcyor.", "file_id": "1420694273935224843", "classifier": {"q1": "yes", "q2": "IGNORED", "q3": "IGNORED", "q4": "IGNORED", "q5": "no_no_need_to_check", "q6": "no_not_harmful", "q7": "no_not_interesting", "comment": ""}}}]